Akoya Biosciences Inc

Akoya Biosciences Inc(AKYA)の株式分析

$1.290

-0.066 (-5.15%)終値時点

Loading chart…
高値
1.640
始値
1.410
出来高加重平均価格
1.41
出来高
715.25K
時価総額
120.50M
安値
1.290
売買代金
1.01M
EV/EBITDA(TTM)
-7.63

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. It offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays.

www.akoyabio.com

バリュエーション指標

Akoya Biosciences Inc(AKYA)の現在の予想PERは-2.50で、5年平均は-5.35です。

予想PER

割高
5年平均 P/E
-5.35
現在のP/E
-2.50
割高
-3.00
割安
-7.70

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-9.06
現在のEV/EBITDA
-7.63
割高
-4.10
割安
-14.03

予想PSR

割安
5年平均 P/S
3.27
現在のP/S
0.81
割高
5.39
割安
1.16

Alphio AI による AKYA の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%AKYA

$1.21

シナリオ価格

基

基本

基本 · 50%AKYA

$0.95

シナリオ価格

弱

弱気

弱気 · 25%AKYA

$0.73

シナリオ価格

イベントタイムライン

2025-04-30 (ET)

08:29:12

Quanterix shareholder issues statement on Akoya Biosciences merger pact

2025-04-29 (ET)

08:02:26

Quanterix, Akoya Biosciences announce amended merger agreement

2025-04-24 (ET)

08:25:33

Akoya expands portfolio with new ADC breast cancer assay at AACR 2025

08:23:33

Akoya Biosciences, Enable Medicine launch single-cell spatial proteomics atlas

2025-04-23 (ET)

08:03:32

Akoya Biosciences, STCC partner on SUPER study for cancer immunophenotyping

ニュース

AKYA のよくある質問 — Alphio AI が回答

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. It offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める